Hypermethylation of CFTR resulting in transcriptional deactivation constitutes a common hallmark of NSCLC (Son et al. 2011) and reduced CFTR expression is significantly correlated with advanced disease stage and lymph node metastasis (Li et al. 2015). This evidence concerns the gene CFTR and non-small cell lung carcinoma.